22 results
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
6 Dec 22
COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States
7:40am
biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today that their supplier has received an Emergency Use
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
6 Dec 22
COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States
7:40am
Biolabs Group Limited issued a press release announcing that their supplier has received an Emergency Use Authorization (“EUA”) from the U.S. FDA
20-F
2022 FY
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Aug 22
Annual report (foreign)
4:20pm
refer to “Key Supplier Relationship” in this section.
Expanding Research and Development Capabilities
Our Group has invested significant resources … of the proprietary intellectual property rights of our supplier to particular territories. For instance, ViraxClear owns the exclusive right for distribution in Canada
6-K
EX-99.4
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
26 Jul 22
Current report (foreign)
7:36am
, or recommend that another person place a purchase or sale order, in the securities of another corporation (such as a supplier, an acquisition target
6-K
EX-14.1
lxnml 89icu97r
26 Jul 22
Current report (foreign)
7:36am
424B4
h2c9tj5valtjbzvq
21 Jul 22
Prospectus supplement with pricing info
10:01am
F-1/A
9qsb1
24 Jun 22
Registration statement (foreign) (amended)
9:47pm
F-1/A
rbin 4z9008zsq
24 Jun 22
Registration statement (foreign) (amended)
8:21am
F-1/A
m9pwnqnq
21 Jun 22
Registration statement (foreign) (amended)
6:26am
F-1/A
puxera21te78jbta2e0k
6 Jun 22
Registration statement (foreign) (amended)
6:13pm
F-1/A
q70ethw 6336v
11 May 22
Registration statement (foreign) (amended)
3:11pm
F-1/A
zra l2m3ipx
22 Apr 22
Registration statement (foreign) (amended)
6:09pm
F-1
EX-10.1
v360h
18 Mar 22
Registration statement (foreign)
3:50pm
F-1
lc5 sb2e01lzh
18 Mar 22
Registration statement (foreign)
3:50pm
F-1
EX-99.1
8nn c0kfqzt
18 Mar 22
Registration statement (foreign)
3:50pm
CORRESP
7bbgxfx0m3y7ow6v au
18 Mar 22
Correspondence with SEC
12:00am
UPLOAD
zv7la
10 Mar 22
Letter from SEC
12:00am
DRSLTR
v73 niiu368vpo
17 Feb 22
Correspondence regarding draft registration statement
12:00am
DRS/A
scq3b8uiv49uoy1
17 Feb 22
Draft registration statement (amended)
12:00am